CMS Extends Medicare’s Short-Term Bridge Program for GLP-1 Obesity Drug Coverage

KFF Medicare

Extending the short-term GLP-1 Bridge program is good news for eligible Medicare beneficiaries because it provides the certainty of obesity drug coverage at a $50 copay for a longer duration, but fede

Market AccessMetabolic & GLP-1Read full story